Perspectives
Nature Reviews Drug Discovery 6, 871-880 (November 2007) | doi:10.1038/nrd2381
Opinion: Proteins, drug targets and the mechanisms they control: the simple truth about complex networks
Robyn P. Araujo1, Lance A. Liotta1 & Emanuel F. Petricoin1 About the authors
Abstract
Realizing the promise of molecularly targeted inhibitors for cancer therapy will require a new level of knowledge about how a drug target is wired into the control circuitry of a complex cellular network. Here we review general homeostatic principles of cellular networks that enable the cell to be resilient in the face of molecular perturbations, while at the same time being sensitive to subtle input signals. Insights into such mechanisms may facilitate the development of combination therapies that take advantage of the cellular control circuitry, with the aim of achieving higher efficacy at a lower drug dosage and with a reduced probability of drug-resistance development.
Author affiliations
- The authors are all at the Center for Applied Proteomics and Molecular Medicine, George Mason University, 10900 University Boulevard, Manassas, Virginia 20109, USA.
Correspondence to: Robyn P. Araujo1 Email: raraujo@gmu.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Integrating cell-level kinetic modeling into the design of engineered protein therapeuticsNature Biotechnology Research (01 Feb 2005)
